MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB

Figure 2

Identification of miRNAs that are decreased in CAD patients compared to healthy subjects. TaqMan miRNA assays were performed on RNA isolated from blood obtained from 2 different groups: patients with angiographically significant CAD (𝑛=15) and healthy volunteers (𝑛=5). P values: miR-19a =  .012, miR-584 =  .036, miR-155 =  .002, miR-222 =  .001, miR-145 =  .008, miR-29a =  .012, miR-378 =  .001, miR-342 =  .001, miR-30e-5p =  .02, and miR-150 =  .006.